| October 27, 2011 |
VALEANT ANNOUNCES TAKE-UP OF ADDITIONAL AFEXA SHARES AND SPECIAL MEETING OF SHAREHOLDERS OF AFEXA TO APPROVE ITS PRIVATIZATION
|
| October 27, 2011 |
AFEXA ANNOUNCES ADDITIONAL TAKE-UP OF SHARES UNDER VALEANT OFFER AND SPECIAL MEETING OF SHAREHOLDERS TO APPROVE THE PRIVATIZATION OF AFEXA |
| October 18, 2011 |
VALEANT ANNOUNCES RESULTS OF FRIENDLY OFFER FOR AFEXA LIFE SCIENCES INC.
|
| October 18, 2011 |
News Release – AFEXA ANNOUNCES TAKE-UP OF SHARES UNDER VALEANT OFFER
|
| October 17, 2011 |
VALEANT - NOTICE OF EXTENSION
|
| October 4, 2011 |
News Release: AFEXA FILES NOTICE OF CHANGE TO DIRECTORS’ CIRCULARS
|
| October 3, 2011 |
NOTICE OF VARIATION
|
| October 3, 2011 |
Cover letter from Valeant mailed with Directors’ Circular
|
| October 3, 2011 |
Notice of Change mailed with Directors' circular
|
| October 3, 2011 |
Cover letter mailed with Directors' circular
|
| September 30, 2011 |
AMENDMENT TO THE ACQUISITION SUPPORT AGREEMENT |
| September 30, 2011 |
News Release – VALEANT ANNOUNCES THAT AFEXA SUPPORTS AND RECOMMENDS VALEANT’S INCREASED OFFER AND AGREES TO CERTAIN AMENDMENTS TO SUPPORT AGREEMENT
- Valeant’s increased offer is C$0.85 per Afexa common share
- Offer no longer subject to a minimum tender condition, comparable to Paladin's no minimum tender condition, providing greater certainty of completion
- Break up fee increased from C$3.75 million to C$4.5 million, which is proportional to the increase in aggregate purchase price under Valeant's offer
|
| September 30, 2011 |
News Release: Afexa Provides Recommendation That Shareholders Accept the Increased Valeant Offer |
| September 26, 2011 |
News Release – VALEANT PHARMACEUTICALS INTENDS TO RAISE OFFER FOR AFEXA LIFE SCIENCES INC. TO $0.85 PER SHARE
- Increased offer subject to Afexa’s agreement to certain amendments to support agreement
- Represents a premium over Paladin Labs’ most recent offer
|
| September 9, 2011 |
Valeant News Release regarding takeover bid |
| September 9, 2011 |
News Release: Afexa mails circular in support of Valeant Offer and Appoints Interim CEO for transition |
| September 9, 2011 |
Afexa mails Directors’ Circular recommending acceptance of Valeants’ offer |
| September 9, 2011 |
Cover letter mailed with Directors’ circular |
| September 9, 2011 |
Valeant mails takeover bid circular to Afexa shareholders |
| September 9, 2011 |
Cover letter from Valeant mailed with Directors’ Circular |
| August 30, 2011 |
News Release: Afexa agrees to support an offer by Valeant Pharmaceuticals; definitive acquisition support agreement |
| August 30, 2011 |
Valeant announces all-cash offer to acquire Afexa |
| August 30, 2011 |
Acquisition Support Agreement filed on SEDAR |
